| 前收市價 | 866.80 |
| 開市 | 874.50 |
| 買盤 | 884.10 x 0 |
| 賣出價 | 886.60 x 0 |
| 今日波幅 | 867.30 - 886.60 |
| 52 週波幅 | 504.40 - 932.00 |
| 成交量 | |
| 平均成交量 | 2,744,119 |
| 市值 | 3.955T |
| Beta 值 (5 年，每月) | 0.19 |
| 市盈率 (最近 12 個月) | 47.62 |
| 每股盈利 (最近 12 個月) | 18.62 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 12.80 (1.44%) |
| 除息日 | 2024年3月22日 |
| 1 年預測目標價 | 905.68 |
Investor's Business DailyDow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
Investor's Business DailyIs Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
ZacksZacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
